Main menu

Accelerating precision oncology: Real-time genomic and epigenomic profiling with Oxford Nanopore

cancer still
resources.return_to_resources
  • shared.published_on: May 11 2026

Recorded at AACR 2026, this video highlights how real-time Oxford Nanopore sequencing is transforming precision oncology through rapid genomic and epigenomic profiling.

Dr. Parth S. Shah (Geisel School of Medicine at Dartmouth) presents his approach to accelerating the molecular characterisation of hematologic malignancies using nanopore sequencing. Dr. Bastiaan Tops (Princess Maxima Center) showcases a rapid, methylation-based classification workflow for CNS tumours.

Together, these presentations will demonstrate how rapid molecular insights can be leveraged to inform clinical decision-making and advance time-critical cancer care.

resources.authors: Parth S. Shah (Geisel School of Medicine at Dartmouth), Bastiaan Tops (Princess Maxima Center), Ellie Juarez (Oxford Nanopore Technologies)

入門

MinION Starter Packを購入 ナノポア製品の販売 シークエンスサービスプロバイダー グローバルディストリビューター

お問い合わせ

Intellectual property Cookie policy Corporate reporting Privacy policy Terms, conditions and policies Modern slavery policy Accessibility

Oxford Nanoporeについて

Contact us 経営陣 メディアリソース & お問い合わせ先 投資家向け Oxford Nanopore社で働く BSI 27001 accreditationBSI 90001 accreditationBSI mark of trust

© 2008 - 2023 Oxford Nanopore Technologies plc. All rights reserved. 登記された事務所：Gosling Building,\n Edmund Halley Road, Oxford Science Park, OX4 4DQ, UK {'|'} 登記番号：05386273 {'|'} VAT番号：336942382。Oxford\n Nanopore Technologies、Wheel icon、EPI2ME、Flongle、GridION、Metrichor、MinION、MinIT、MinKNOW、Plongle、\n PromethION、SmidgION、UbikおよびVolTRAXは様々な国で登録されたOxford Nanopore Technologies\nの商標です。Oxford Nanopore Technologies製品は、\n現在すべて研究用です。

Japanese flag